Last reviewed · How we verify

NCT03977909: SPIBIP

Early Maladaptative Schemas Among Euthymic Patients With Bipolar Disorder in the Versailles FondaMental Advanced Centers of Expertise for Bipolar Disorders Cohort

Status unknown Last updated 30 August 2023
What this trial tests

trial in Bipolar Disorder in 150 participants. Status unknown.

Timeline
1 July 2009
Primary endpoint
1 December 2024
1 December 2024

Quick facts

Lead sponsorVersailles Hospital
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment150
Start date1 July 2009
Primary completion1 December 2024
Estimated completion1 December 2024
Sites1 location across France

Conditions studied

Sponsor

Versailles Hospital

Who can join

Adults 18 to 65, any sex, with Bipolar Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Early Maladaptive Schemas (EMS) are overactivated in euthymic bipolar disorders (BD) and are associated with poor psychosocial functioning and higher suicidality. The first objective of this study is to establish different clusters of EMS in euthymic bipolar disorders, compare these clusters according to the clinical characteristics of BD and neuropsychological performances and evaluate the temporal stability of these clusters at 12 and 24 months. The second objective of this study is to quantify the impact of EMS on functioning in euthymic BD, beyond the effect of cognition and residual depressive symptoms.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Bipolar Disorder

Currently open trials in the same condition.

Other Versailles Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03977909.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing